Header Logo

Connection

MILIND JAVLE to Translocation, Genetic

Back to Details
This is a "connection" page, showing publications MILIND JAVLE has written about Translocation, Genetic.
MILIND JAVLE
Connection Strength
0.031
Translocation, Genetic
  1. Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial. Future Oncol. 2020 Oct; 16(30):2375-2384.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.